Medical and Surgical Treatment for Idiopathic Granulomatous Mastitis — MSTIGM  

Granulomatous Mastitis Clinical Trial

Official title: Evaluation of Topical Steroids and Surgical Treatment for Idiopathic Granulomatous Mastitis

Status Recruiting

Clinical Trial Summary

This study evaluates the clinical response rate of topical steroids in the treatment of idiopathic granulomatous mastitis in female adults. Half of the participants will receive topical steroid and the other half will receive local wide surgical excision.

Clinical Trial Description

Idiopathic granulomatous mastitis (IGM) is a rare benign inflammatory breast disease of unknown etiology.It may present with many findings that clinically and radiologically mimic breast cancer.

Although IGM as a disease has been known for nearly four decades, the optimal treatment approach has not been established. Surgical intervention in the form of wide surgical excision was the mainstay of treatment before 1980, and is still performed depending on local expertise and preference.

Currently,surgical treatment and systemic steroid treatment are frequently employed. With the consideration of side effects of longterm systemic (oral) steroid usage, topical steroid without systemic use were assessed and showed satisfactory curative effect. But the data concerning the use of topical steroid therapy are still very limited. ;

Related Conditions & MeSH terms

• Granulomatous Mastitis
• Mastitis

• NCT number: NCT02959580
• Study type: Interventional
• Source: Peking Union Medical College Hospital
• Contact: Yanna Zhang, M.D.
• Phone: 86-10-69158703
• Email: pumchzyn@sohu.com
• Status: Recruiting
• Phase: Phase 4
• Start date: January 1, 2017
• Completion date: September 2020